Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06723821

Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain

Effectiveness of Noninvasive Neuromodulation in Post-COVID Musculoskeletal Pain in the Short Term: Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Alcala · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Brief Summary: The post-Covid syndrome is a problem that affects a significant number of people in the world. Among the most common symptoms is pain, and although there is no specific data on neuropathic pain and Covid, due to under-diagnosis, they may be closely related. Non-invasive neuromodulation acts on the Central Nervous System through the bioelectrical stimulation of nervous tissue and modulation of the system nervous, and can be useful in acute, chronic and musculosqueletal pain, and in symptoms such as stress, anxiety and sleep disturbances. The objective of this clinical trial is to assess the efficacy of non-invasive neuromodulation in the treatment of post-Covid musculoskeletal pain. Subjects will be randomly divided into two groups: an experimental group in which non-invasive neuromodulation will be applied and a sham group to which it will be applied off. The variables to be studied before, during and after treatment will be neuropathic pain with the DN4 questionnaire, pain intensity with the EVA scale, sleep quality with the Pittsburgh Sleep Quality Index, level of stress and anxiety with the HADS questionnaire and quality of life with the SF12.

Conditions

Interventions

TypeNameDescription
OTHERNeuromodulation groupDuring the 12 sessions of which the treatment consists in applying 60 minutes of microcurrent in low intensity.
OTHERNeuromodulation sham groupDuring the 12 sessions of which the treatment consists in applying 60 minutes of sham microcurrent in low intensity.

Timeline

Start date
2024-12-15
Primary completion
2025-10-15
Completion
2025-11-15
First posted
2024-12-09
Last updated
2025-06-03

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06723821. Inclusion in this directory is not an endorsement.